Cite
MLA Citation
Russell D Cohen et al.. “The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data.” Journal of Crohn's and colitis, vol. 14, 2020, pp. 192–204. http://access.bl.uk/ark:/81055/vdc_100099967900.0x000009